Z8W-10811-64746
2 vaccinations
5 coded responses
19 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 723 / AR
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Survey response — days 1–6 daily, dose 1MedDRA: Arthralgia, Injection site pain, Pain — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body achesFree text: Site soreness seems to be worse today, hurts to raise arm and pain from deltoid into scapular/shoulder region. Mild to moderate all dayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-09
-
2021-01-15
Survey response — day 7, dose 1MedDRA: Feeling abnormal, SARS-CoV-2 test negative — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Informed I was a contact of + at work. Have felt bad all week. Tested with PCR today, had 2 prior - in the last 2 weeks, as did she. Took care of 4 + pt last week, same day revived 1st vac doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
-
2021-01-28
Dose 2 — Pfizer-BioNTech
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
- 2021-02-18
-
2021-02-25
Survey response — day 28, dose 2MedDRA: Headache, Nasal congestion, Sensitivity to weather change — Feeling: FairFree text: Sinus congestion Migraine headaches Most likely from weather changes not vac relatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
-
2021-03-11
Survey response — day 42, dose 2MedDRA: Migraine — Feeling: GoodFree text: More frequent migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
- 2021-07-29
-
2022-01-28
Survey response — 12 months, dose 2MedDRA: COVID-19, Diarrhoea, Fatigue, Headache, Postmenopausal haemorrhage, Pyrexia, Quarantine, Telemedicine, Vision blurred — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: + for COVID, quarantined x 10 D. Spouse also +, child stayed - . Severe headache, temp 103.6 x 24 hrs, 101.6-8 days 2-5. diarrhea for 5-7 days after that. Fatigue continues. Also blurry vision in afternoons. Post-menopausal bleeding 10 days after +. · Healthcare visit (other): I am an APRN, did a telehealth with my MD I work with plus self tx at home.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-09
- 2022-02-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-28 | Unsuccessful |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Site soreness seems to be worse today, hurts to raise arm and pain from deltoid into scapular/shoulder region. Mild to moderate all day
Release 2 — day 7, dose 1
Systemic reaction (other): Informed I was a contact of + at work. Have felt bad all week. Tested with PCR today, had 2 prior - in the last 2 weeks, as did she. Took care of 4 + pt last week, same day revived 1st vac dose
Release 4 — day 28, dose 2
Symptoms: Sinus congestion Migraine headaches Most likely from weather changes not vac related
Release 5 — day 42, dose 2
Symptoms: More frequent migraines
Release 11 — 12 months, dose 2
Symptoms: + for COVID, quarantined x 10 D. Spouse also +, child stayed - . Severe headache, temp 103.6 x 24 hrs, 101.6-8 days 2-5. diarrhea for 5-7 days after that. Fatigue continues. Also blurry vision in afternoons. Post-menopausal bleeding 10 days after +. cut off by CDC
Healthcare visit (other): I am an APRN, did a telehealth with my MD I work with plus self tx at home.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Telemedicine | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Postmenopausal haemorrhage | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Quarantine | · | · | ✓ |
| SD | Sensitivity to weather change | ✓ | ✓ | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release